Suppr超能文献

糖尿病和高血压对 COVID-19 感染严重程度和死亡率的有害影响:来自印度的一项多中心病例对照研究。

Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.

机构信息

Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, Hauz Khas, New Delhi, 110016, India.

Department of Anesthesiology and Critical Care, Armed Forces Medical College, Pune, 411040, Maharashtra, India.

出版信息

Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102248. doi: 10.1016/j.dsx.2021.102248. Epub 2021 Aug 15.

Abstract

AIMS

This study aims to find a quantitative association between the presence of co-existing diabetes mellitus (DM) and/or hypertension (HTN) with COVID-19 infection severity and mortality.

METHODS

A total of 813 patients with a positive COVID-19 were included. A case-control design was used to dissect the association between DM and HTN with COVID-19 severity and mortality.

RESULTS

According to MOHFW guidelines, 535 (65.7%) patients had mild, 160 (19.7%) patients had moderate, and 118 (14.5%) patients had severe disease outcomes including mortality in 52 patients. Age, Neutrophil%, and Diabetes status were significantly associated with severe COVID-19 infection. After adjusting for age, patients with diabetes were 2.46 times more likely to have severe disease (Chi-squared = 18.89, p-value<0.0001) and 2.11 times more likely to have a fatal outcome (Chi-squared = 6.04, p-value = 0.014). However, we did not find evidence for Hypertension modifying the COVID-19 outcomes in Diabetic patients.

CONCLUSION

COVID-19 severity and mortality both were significantly associated with the status of DM and its risk may not be modified by the presence of HTN.

摘要

目的

本研究旨在探讨同时患有糖尿病(DM)和/或高血压(HTN)与 COVID-19 感染严重程度和死亡率之间是否存在定量关联。

方法

共纳入 813 例 COVID-19 阳性患者。采用病例对照设计来剖析 DM 和 HTN 与 COVID-19 严重程度和死亡率之间的关联。

结果

根据 MOHFW 指南,535 例(65.7%)患者为轻症,160 例(19.7%)患者为中度,118 例(14.5%)患者为重症,包括 52 例死亡。年龄、中性粒细胞%和糖尿病状况与严重 COVID-19 感染显著相关。在调整年龄后,患有糖尿病的患者发生重症疾病的可能性是未患糖尿病患者的 2.46 倍(卡方检验=18.89,p 值<0.0001),且发生致死性结局的可能性是未患糖尿病患者的 2.11 倍(卡方检验=6.04,p 值=0.014)。然而,我们并未发现 HTN 存在会改变糖尿病患者 COVID-19 结局的证据。

结论

COVID-19 的严重程度和死亡率均与 DM 状况显著相关,其风险可能不受 HTN 的影响。

相似文献

引用本文的文献

1
The Impact of Vaccination on COVID-19 Outcomes in Vietnam.疫苗接种对越南新冠疫情结局的影响
Diagnostics (Basel). 2024 Dec 18;14(24):2850. doi: 10.3390/diagnostics14242850.

本文引用的文献

6
Diabetes and COVID-19: a major challenge in pandemic period?糖尿病与 COVID-19:大流行时期的重大挑战?
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11409-11420. doi: 10.26355/eurrev_202011_23634.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验